| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.03 |